Evidence map›Paper›PMID 32713802›Full record

ReviewBest practice & research. Clinical rheumatology2020

Global health policy in the 21st century: Challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions.

Andrew M Briggs, Jeremy Shiffman, Yusra Ribhi Shawar, Kristina Åkesson, Nuzhat Ali, Anthony D Woolf

Open access · greenAbstract readReview
In one paragraph

Review in Best practice & research. Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Andrew M BriggsSchool of Physiotherapy and Exercise Science, Curtin University, GPO Box 1987, Perth, WA, 6845, Australia. Electronic address: A.Briggs@curtin.edu.au.
Jeremy ShiffmanJohns Hopkins Bloomberg School of Public Health, John Hopkins University, 615 N. Wolfe St., E8539, Baltimore, MD, 21205, United States. Electronic address: Jeremy.Shiffman@jhu.edu.
Yusra Ribhi ShawarJohns Hopkins Bloomberg School of Public Health, John Hopkins University, 615 N. Wolfe St., E8539, Baltimore, MD, 21205, United States. Electronic address: yusra.shawar@jhu.edu.
Kristina ÅkessonDepartment of Clinical Sciences, Lund University, Malmö, Sweden; Clinical and Molecular Osteoporosis Research Unit, Department of Geriatrics, Skåne University Hospital, Malmö, Sweden. Electronic address: kristina.akesson@med.lu.se.
Nuzhat AliPriority and Programmes Division, Health Improvement Directorate, Public Health England, Wellington House, 133- 155 Waterloo Road, Waterloo, SE1 8UG, United Kingdom. Electronic address: Nuzhat.Ali@phe.gov.uk.
Anthony D WoolfBone and Joint Research Group, Royal Cornwall Hospital, Truro, TR1 3HD, United Kingdom. Electronic address: Anthony.Woolf@btopenworld.com.
Johns Hopkins University · USCurtin University · AULund University · SEPublic Health England · GBRoyal Cornwall Hospital Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The profound burden of disease associated with musculoskeletal health conditions is well established. Despite the unequivocal disability burden and personal and societal consequences, relative to other non-communicable diseases (NCDs), system-level responses for musculoskeletal conditions that are commensurate with their burden have been lacking nationally and globally. Health policy priorities and responses in the 21st century have evolved significantly from the 20th century, with health systems now challenged by an increasing prevalence and impact of NCDs and an unprecedented rate of global population ageing. Further, health policy priorities are now strongly aligned to the 2030 Sustainable Development Goals. With this background, what are the challenges and opportunities available to influence global health policy to support high-value care for musculoskeletal health conditions and persistent pain? This paper explores these issues by considering the current global health policy landscape, the role of global health networks, and progress and opportunities since the 2000-2010 Bone and Joint Decade for health policy to support improved musculoskeletal health and high-value musculoskeletal health care.

Indexed as

Musculoskeletal DiseasesNoncommunicable DiseasesPersons with DisabilitiesGlobal HealthHealth PolicyHumansGlobal healthHealth systemMusculoskeletalNetworkNon-communicable diseasePainPolicy

Identifiers

PMID32713802
PMCPMC7377715
OpenAlexW3045155733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.